Category: Department News
As COVID-19 Cases Surge, Wohl Recognizes the Need to Return to Mask Rules
With COVID-19 cases rising, will mask mandates return to North Carolina? A CBS-17 news report says Los Angeles and several California cities have gone back to mandatory mask wearing. Lawmakers in Arkansas and Missouri are also talking about reimposing the restriction. David Wohl, MD, professor of medicine in the division of infectious diseases, said he believes it’s time for mask … Continued
COVID-19 Delta Variant Q & A with Drs. Cindy Gay and David Wohl
Cindy Gay, MD, and David Wohl, MD, are featured in a new video about the COVID-19 Delta variant, vaccine efficacy and mRNA vaccine safety. Dr. Gay is an associate professor in the division of infectious diseases and leads vaccine clinical trials at UNC for the Moderna and Novavax vaccines. Dr. Wohl is professor of medicine in infectious diseases, who led the UNC-Chapel Hill vacc … Continued
Buse Explains Type 1.5 Diabetes
Diabetes as we know it is typically organized into two neat categories: type 1 and type 2. In type 1 diabetes, antibodies from your own immune system destroy the cells which produce insulin. The disease starts suddenly and is usually diagnosed in children. Type 2 diabetes most often develops in adults as a result of insulin resistance (your cells don’t use the insulin well), not … Continued
UNC SOM Appoints Larson Electives Director
The School of Medicine is excited to welcome Claire Larson, MD, to the role of Director of Electives, coordinating elective offerings across all phases including the scholarly concentrations. Dr. Larson earned her medical degree from the UNC School of Medicine and completed Internal Medicine and Geriatrics training at the University of California, San Francisco. From clinical pra … Continued
-
Wohl Contributed to Recent News Stories About COVID-19 Variants
NC Medical Schools, Health Systems Forming Network to Analyze Delta Variant The latest data shows the Delta variant represents about 13 percent of COVID-19 cases in North Carolina, but that data is about a month old, according to a CBS-17 news report published July 18, 2021. “It is inevitable this is going to be the dominant virus here very, very shortly,” said David Wohl, MD, pr … Continued
Outpatient Diuresis Clinic, VCAG Project Keeps Serving
Patient-Centered Multidisciplinary Approach Provides Clinic Based Treatment Historically Accessed By ED Visit For patients with heart failure, hospitalizations can be a recurring part of life, affecting the lives of both patients and their caregivers. Driven by symptoms like shortness of breath or swelling of the feet, legs, and ankles, these are costly encounters, and historical … Continued
Advances Propel Lung Cancer Paradigms Forward to Improved Outcomes and Quality of Life
Among a plethora of novel immunotherapeutic and targeted agents, the treatment landscapes for small cell lung cancer and non–small cell lung cancer have witnessed a rapid expansion that has led to improved survival and quality of life for patients, including a wider range of patients who harbor molecular abnormalities. In an interview with OncLive® during an Institutional Perspec … Continued
Study Compares Mortality Among People Entering HIV Care with General US Population
HIV-related mortality has decreased since 1996 due to improving treatments and evolving care guidelines, but the extent to which persons entering HIV care have a higher risk for death over the following years, compared with peers in the general population, has been unclear. Joseph Eron, MD, the Herman and Louise Smith Distinguished Professor of Medicine and chief of the division … Continued
Message From Our Vice Chair For Diversity and Inclusion
“Not everything that is faced can be changed, but nothing can be changed until it is faced.” – James Baldwin, New York Times, 1962 A little over a year ago, I penned a statement reflecting on how we cope following the senseless and tragic killings of Mr. George Floyd, Ms. Breona Taylor, and Mr. Ahmaud Arbery. With input from some of my trusted colleagues, that piece was written t … Continued
Study Finds Bamlanivimab Reduces Risk of COVID in Skilled Nursing Homes and Assisted Living Facilities
Myron Cohen, MD, is the lead investigator of a study recently published in the Journal of the American Medical Association (JAMA) that shows bamlanivimab monotherapy reduced the incidence of infection in skilled nursing homes and assisted living facilities with high risk of SARS-CoV-2 exposure. The randomized phase 3 clinical trial included 966 residents and staff participants fr … Continued